Cargando…
Characteristics and survival of patients with cancer with intended off-label use—a cohort study
OBJECTIVE: To describe the characteristics and the survival of patients with cancer with intended off-label use (OLU) cancer treatment and reimbursement request. DESIGN: Cohort study using medical record data. SETTING: Three major cancer centres in Switzerland. PARTICIPANTS: 519 patients with cancer...
Autores principales: | Schmitt, Andreas Michael, Walter, Martin, Herbrand, Amanda Katherina, Jörger, Markus, Moffa, Giusi, Novak, Urban, Hemkens, Lars, Kasenda, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125762/ https://www.ncbi.nlm.nih.gov/pubmed/35613810 http://dx.doi.org/10.1136/bmjopen-2021-060453 |
Ejemplares similares
-
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
por: Herbrand, Amanda Katherina, et al.
Publicado: (2021) -
Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project
por: Herbrand, Amanda Katherina, et al.
Publicado: (2019) -
Characteristics and interpretation of subgroup analyses based on tumour characteristics in randomised trials testing target-specific anticancer drugs: design of a systematic survey
por: Schandelmaier, Stefan, et al.
Publicado: (2020) -
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study
por: Kasenda, Benjamin, et al.
Publicado: (2020) -
Editorial: Investigating drugs used off-label in various cancers
por: Liu, Wang, et al.
Publicado: (2023)